201 related articles for article (PubMed ID: 36145851)
1. Harnessing Lipid Polymer Hybrid Nanoparticles for Enhanced Oral Bioavailability of Thymoquinone: In Vitro and In Vivo Assessments.
Imam SS; Gilani SJ; Bin Jumah MN; Rizwanullah M; Zafar A; Ahmed MM; Alshehri S
Polymers (Basel); 2022 Sep; 14(18):. PubMed ID: 36145851
[TBL] [Abstract][Full Text] [Related]
2. Formulation of Piperine Nanoparticles: In Vitro Breast Cancer Cell Line and In Vivo Evaluation.
Kazmi I; Al-Abbasi FA; Imam SS; Afzal M; Nadeem MS; Altayb HN; Alshehri S
Polymers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406223
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments.
Rahat I; Imam SS; Rizwanullah M; Alshehri S; Asif M; Kala C; Taleuzzaman M
Drug Deliv; 2021 Dec; 28(1):973-984. PubMed ID: 34036860
[TBL] [Abstract][Full Text] [Related]
4. Development and In Vitro Evaluation of Crizotinib-Loaded Lipid-Polymer Hybrid Nanoparticles Using Box-Behnken Design in Non-small Cell Lung Cancer.
Korucu Aktas P; Baysal I; Yabanoglu-Ciftci S; Arica B
AAPS PharmSciTech; 2023 Sep; 24(7):178. PubMed ID: 37658977
[TBL] [Abstract][Full Text] [Related]
5. Development and
Yousaf R; Khan MI; Akhtar MF; Madni A; Sohail MF; Saleem A; Irshad K; Sharif A; Rana M
Heliyon; 2023 Mar; 9(3):e14281. PubMed ID: 36925532
[TBL] [Abstract][Full Text] [Related]
6. EGF-functionalized lipid-polymer hybrid nanoparticles of 5-fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinoma.
Li S; Xu Z; Alrobaian M; Afzal O; Kazmi I; Almalki WH; Altamimi ASA; Al-Abbasi FA; Alharbi KS; Altowayan WM; Singh T; Akhter MH; Gupta M; Rahman M; Beg S
Biotechnol Appl Biochem; 2022 Oct; 69(5):2205-2221. PubMed ID: 34775646
[TBL] [Abstract][Full Text] [Related]
7. Efficient in vitro and in vivo docetaxel delivery mediated by pH-sensitive LPHNPs for effective breast cancer therapy.
Jadon RS; Sharma G; Garg NK; Tandel N; Gajbhiye KR; Salve R; Gajbhiye V; Sharma U; Katare OP; Sharma M; Tyagi RK
Colloids Surf B Biointerfaces; 2021 Jul; 203():111760. PubMed ID: 33872827
[TBL] [Abstract][Full Text] [Related]
8. Core Shell Lipid-Polymer Hybrid Nanoparticles for Oral Bioavailability Enhancement of Ibrutinib via Lymphatic Uptake.
Patel M; Desai A; Kansara V; Vyas B
AAPS PharmSciTech; 2023 Jun; 24(6):142. PubMed ID: 37353671
[TBL] [Abstract][Full Text] [Related]
9. Baicalin-Loaded Lipid-Polymer Hybrid Nanoparticles Inhibiting the Proliferation of Human Colon Cancer: Pharmacokinetics and In Vivo Evaluation.
Riadi Y; Afzal O; Geesi MH; Almalki WH; Singh T
Polymers (Basel); 2023 Jan; 15(3):. PubMed ID: 36771901
[TBL] [Abstract][Full Text] [Related]
10. Investigating the effectiveness of Difluprednate-Loaded core-shell lipid-polymeric hybrid nanoparticles for ocular delivery.
Kaviarasi B; Rajana N; Pooja YS; Rajalakshmi AN; Singh SB; Mehra NK
Int J Pharm; 2023 Jun; 640():123006. PubMed ID: 37137420
[TBL] [Abstract][Full Text] [Related]
11. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
[TBL] [Abstract][Full Text] [Related]
12. Statistically Optimized Tacrolimus and Thymoquinone Co-Loaded Nanostructured Lipid Carriers Gel for Improved Topical Treatment of Psoriasis.
Alam M; Rizwanullah M; Mir SR; Amin S
Gels; 2023 Jun; 9(7):. PubMed ID: 37504393
[TBL] [Abstract][Full Text] [Related]
13. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery.
Tahir N; Madni A; Li W; Correia A; Khan MM; Rahim MA; Santos HA
Int J Pharm; 2020 May; 581():119275. PubMed ID: 32229283
[TBL] [Abstract][Full Text] [Related]
14. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
Abd-Elhakeem E; El-Nabarawi M; Shamma R
Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
[TBL] [Abstract][Full Text] [Related]
15. Conventional and microfluidic methods: Design and optimization of lipid-polymeric hybrid nanoparticles for gene therapy.
González-García D; Tapia O; Évora C; García-García P; Delgado A
Drug Deliv Transl Res; 2024 Jun; ():. PubMed ID: 38872047
[TBL] [Abstract][Full Text] [Related]
16. Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy.
Khan S; Aamir MN; Madni A; Jan N; Khan A; Jabar A; Shah H; Rahim MA; Ali A
Life Sci; 2021 Nov; 284():119909. PubMed ID: 34450169
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer.
Jain A; Sharma G; Kushwah V; Garg NK; Kesharwani P; Ghoshal G; Singh B; Shivhare US; Jain S; Katare OP
Nanomedicine (Lond); 2017 Aug; 12(15):1851-1872. PubMed ID: 28703643
[TBL] [Abstract][Full Text] [Related]
18. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications.
Tahir N; Madni A; Balasubramanian V; Rehman M; Correia A; Kashif PM; Mäkilä E; Salonen J; Santos HA
Int J Pharm; 2017 Nov; 533(1):156-168. PubMed ID: 28963013
[TBL] [Abstract][Full Text] [Related]
19. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization,
Rizwanullah M; Perwez A; Mir SR; Alam Rizvi MM; Amin S
Nanotechnology; 2021 Jul; 32(41):. PubMed ID: 34198267
[TBL] [Abstract][Full Text] [Related]
20. Nanocarrier based formulation of Thymoquinone improves oral delivery: stability assessment, in vitro and in vivo studies.
Singh A; Ahmad I; Akhter S; Jain GK; Iqbal Z; Talegaonkar S; Ahmad FJ
Colloids Surf B Biointerfaces; 2013 Feb; 102():822-32. PubMed ID: 23104039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
